Pacira Pharmaceuticals News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

07.04.14	Pacira Pharma Offering $100 Mln Of Stock (RTTNews)
31.03.14	Pacira Says FDA Approved Additional Manufacturing Suite For Exparel (RTTNews)
27.02.14	Pacira Pharma Says EXPAREL Phase 3 Trial Meets Primary Efficacy Endpoint (RTTNews)
26.02.14	ANIK Needs Your Attention, DARA Gets A Double Blessing, ITMN ASCENDs So High (RTTNews)
02.10.13	ANAC, SLXP Get FDA Date, CERS On A High, MACK On Watch, OGEN And XON Team Up (RTTNews)
30.09.13	Product Launches, Clinical Study Results, Historical Trials, Joint Lawsuits and Milestone Patient Enrollment - Research Report on Teva, Pacira, Novo Nordisk, Forest, and Amarin (PR Newswire)
25.09.13	Drug Recommendations, Presentations, Marketing Authorizations, and Board Appointments - Research Report on Johnson & Johnson, Lilly, Sanofi, GSK, and Pacira (PR Newswire)
19.08.13	Drug Approvals, Clinical Trials, Awards, Offerings, and Earnings - Research Report on J&J, Sanofi, Novartis, BioScrip, and Pacira (PR Newswire)
02.08.13	Pacira's Pain Drug Does Not Meet Primary Goal In Late-stage Study; Stock Down (RTTNews)
02.08.13	ATRC, RGEN See Rosy Future, VICL, INCY To Watch Out For, PCRX Down But Not Out (RTTNews)
02.08.13	After-market Movers For Aug 1(AIG, BAC, LNKD, MELI, WTW, WPRT, ADNC, PCRX, VCLK) (RTTNews)
01.08.13	Pacira's Exparel Ph 3 Trial In Intercostal Nerve Block Fails To Meet Main Goal (RTTNews)
25.07.13	Settlements, Significant Study Results, and Product Launches Lead to Advancements in Patient Care - Research Report on GSK, Isis, Endo, Pacira, and Dr. Reddy's (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	553.80	6.01 %	K V
CieFinRichemont	135.15	1.12 %	K V
Holcim	90.16	1.05 %	K V
UBS Group	28.55	0.88 %	K V
Swiss Re	128.60	0.31 %	K V
Part Grp Hldg	1’293.50	-0.27 %	K V
Sika	231.00	-0.43 %	K V
Swiss Life Hldg	688.60	-0.46 %	K V
Roche Hldg G	254.10	-0.70 %	K V
Kuehne+Nagel Int	203.60	-3.46 %	K V